Bruker/$BRKR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Bruker
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
Ticker
$BRKR
Sector
Primary listing
Employees
11,085
Headquarters
Website
Bruker Metrics
BasicAdvanced
$8.6bn
-
-$0.24
1.12
$0.20
0.35%
Price and volume
Market cap
$8.6bn
Beta
1.12
52-week high
$64.54
52-week low
$28.53
Average daily volume
2.8m
Dividend rate
$0.20
Financial strength
Current ratio
1.552
Quick ratio
0.652
Long term debt to equity
66.442
Total debt to equity
66.777
Interest coverage (TTM)
4.64%
Profitability
EBITDA (TTM)
494.2
Gross margin (TTM)
47.62%
Net profit margin (TTM)
-0.34%
Operating margin (TTM)
7.53%
Effective tax rate (TTM)
168.61%
Revenue per employee (TTM)
$310,000
Management effectiveness
Return on assets (TTM)
2.70%
Return on equity (TTM)
-0.43%
Valuation
Price to revenue (TTM)
2.478
Price to book
3.5
Price to tangible book (TTM)
-327.63
Price to free cash flow (TTM)
10,712.386
Free cash flow yield (TTM)
0.01%
Free cash flow per share (TTM)
0.005
Dividend yield (TTM)
0.35%
Forward dividend yield
0.35%
Growth
Revenue change (TTM)
0.36%
Earnings per share change (TTM)
-145.67%
3-year revenue growth (CAGR)
9.68%
10-year revenue growth (CAGR)
7.71%
3-year earnings per share growth (CAGR)
-51.50%
10-year earnings per share growth (CAGR)
-10.18%
10-year dividend per share growth (CAGR)
17.46%
What the Analysts think about Bruker
Analyst ratings (Buy, Hold, Sell) for Bruker stock.
Bruker Financial Performance
Revenues and expenses
Bruker Earnings Performance
Company profitability
Bruker News
AllArticlesVideos
Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026
Business Wire·2 days ago
Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry
Business Wire·4 days ago
Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology
Business Wire·5 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs